Comment & Analysis

Sun Pharmaceutical Industries’ chances of climbing the pharmaceutical value chain just improved, ...

When thinking about developing markets China often hogs the limelight. But there are other ...

Ultragenyx is expecting phase II readouts from its two most valuable projects in the second half of ...

MedTech

EventAnalyzer

Therapeutic Focus

Market Moving Events

EP Vantage Interviews